JES
Senior Member
- Messages
- 1,374
I was not able to determine how severe or mild their ME was. This is very important. Mona, in the interview, was able to walk 3 miles, even before taking mestinon. Also, I note that Dr Systrom feels the side effects are not that severe. Yet, many patients have been unable to use the drug due to the severe side effects. Also, on his treatment slide, I note the use of anti depressants and Ritalin. Dr. Teitelbaum used these decades ago, and saline has been used decades ago. Ritilin just stimulates the system, and a horrific crash can and likely will ensue--for the core problem has not been addressed. Dr Systom's work looks very thorough, and impressive, and what he says was stated by CFS doctors decades ago (perhaps not proved in a lab). I am very worried that the treatment may not really work for many severe patients. I would dearly like to know how sick these patients were before taking mestinon, were they bedridden, or what. What would he propose for the bedridden, I wonder.
The problem is that a certain number of ME/CFS patients are going to react (badly) to most drugs. I'd imagine for a bedbound patient, drug tolerance will be much less than for e.g. someone mild or moderate. I noticed over the past five years that my tolerance to various foods and supplements have got significantly worse while I'm still quite functioning comparatively speaking. It's worth to note that for mestinon, the dosage used by some POTS doctors is much less, around 10 mg per dose, compared to treatment of myasthenia gravis (50+ mg).
The bigger issue with mestinon is that it's not very effective at least in my experience. The first time I got the opportunity to try mestinon last year, I thought for a moment that it had cured my OI issues. This effected lasted a couple of days after which there was no longer any benefit and it actually seemed to mess up my autonomic nervous system more in the long run. IMO, treatment with neurotransmitter blockers is never going to solve this disease, I think it's a bit analogous to serotonin reuptake inhibition in depression. However, I think the price and safety of this drug makes it a good candidate, but I'm afraid it will be largely wasted effort.